[1]
Bambha K, Kim WR, Talwalkar J, Torgerson H, Benson JT, Therneau TM, Loftus EV Jr, Yawn BP, Dickson ER, Melton LJ 3rd. Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community. Gastroenterology. 2003 Nov:125(5):1364-9
[PubMed PMID: 14598252]
[2]
Chapman RW, Arborgh BA, Rhodes JM, Summerfield JA, Dick R, Scheuer PJ, Sherlock S. Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology. Gut. 1980 Oct:21(10):870-7
[PubMed PMID: 7439807]
[3]
Kim WR, Ludwig J, Lindor KD. Variant forms of cholestatic diseases involving small bile ducts in adults. The American journal of gastroenterology. 2000 May:95(5):1130-8
[PubMed PMID: 10811317]
[4]
Wee A, Ludwig J. Pericholangitis in chronic ulcerative colitis: primary sclerosing cholangitis of the small bile ducts? Annals of internal medicine. 1985 May:102(5):581-7
[PubMed PMID: 3985511]
[5]
Ludwig J. Small-duct primary sclerosing cholangitis. Seminars in liver disease. 1991 Feb:11(1):11-7
[PubMed PMID: 2047885]
[6]
Angulo P, Lindor KD. Primary sclerosing cholangitis. Hepatology (Baltimore, Md.). 1999 Jul:30(1):325-32
[PubMed PMID: 10385674]
[7]
LaRusso NF, Shneider BL, Black D, Gores GJ, James SP, Doo E, Hoofnagle JH. Primary sclerosing cholangitis: summary of a workshop. Hepatology (Baltimore, Md.). 2006 Sep:44(3):746-64
[PubMed PMID: 16941705]
[8]
Naess S, Björnsson E, Anmarkrud JA, Al Mamari S, Juran BD, Lazaridis KN, Chapman R, Bergquist A, Melum E, Marsh SG, Schrumpf E, Lie BA, Boberg KM, Karlsen TH, Hov JR. Small duct primary sclerosing cholangitis without inflammatory bowel disease is genetically different from large duct disease. Liver international : official journal of the International Association for the Study of the Liver. 2014 Nov:34(10):1488-95. doi: 10.1111/liv.12492. Epub 2014 Mar 7
[PubMed PMID: 24517468]
[9]
Broomé U, Glaumann H, Lindstöm E, Lööf L, Almer S, Prytz H, Sandberg-Gertzén H, Lindgren S, Fork FT, Järnerot G, Olsson R. Natural history and outcome in 32 Swedish patients with small duct primary sclerosing cholangitis (PSC). Journal of hepatology. 2002 May:36(5):586-9
[PubMed PMID: 11983440]
[10]
Björnsson E, Olsson R, Bergquist A, Lindgren S, Braden B, Chapman RW, Boberg KM, Angulo P. The natural history of small-duct primary sclerosing cholangitis. Gastroenterology. 2008 Apr:134(4):975-80. doi: 10.1053/j.gastro.2008.01.042. Epub 2008 Jan 17
[PubMed PMID: 18395078]
[11]
Singal AK, Stanca CM, Clark V, Dixon L, Levy C, Odin JA, Fiel MI, Friedman SL, Bach N. Natural history of small duct primary sclerosing cholangitis: a case series with review of the literature. Hepatology international. 2011 Sep:5(3):808-13. doi: 10.1007/s12072-011-9260-4. Epub 2011 Mar 11
[PubMed PMID: 21484124]
Level 2 (mid-level) evidence
[12]
Charatcharoenwitthaya P, Angulo P, Enders FB, Lindor KD. Impact of inflammatory bowel disease and ursodeoxycholic acid therapy on small-duct primary sclerosing cholangitis. Hepatology (Baltimore, Md.). 2008 Jan:47(1):133-42
[PubMed PMID: 17992695]
[13]
Heikius B, Niemelä S, Lehtola J, Karttunen T, Lähde S. Hepatobiliary and coexisting pancreatic duct abnormalities in patients with inflammatory bowel disease. Scandinavian journal of gastroenterology. 1997 Feb:32(2):153-61
[PubMed PMID: 9051876]
[14]
Tabibian JH, Ali AH, Lindor KD. Primary Sclerosing Cholangitis, Part 1: Epidemiology, Etiopathogenesis, Clinical Features, and Treatment. Gastroenterology & hepatology. 2018 May:14(5):293-304
[PubMed PMID: 29991937]
[15]
Pollheimer MJ, Halilbasic E, Fickert P, Trauner M. Pathogenesis of primary sclerosing cholangitis. Best practice & research. Clinical gastroenterology. 2011 Dec:25(6):727-39. doi: 10.1016/j.bpg.2011.10.009. Epub
[PubMed PMID: 22117638]
[16]
O'Mahony CA, Vierling JM. Etiopathogenesis of primary sclerosing cholangitis. Seminars in liver disease. 2006 Feb:26(1):3-21
[PubMed PMID: 16496229]
[17]
Grant AJ, Lalor PF, Salmi M, Jalkanen S, Adams DH. Homing of mucosal lymphocytes to the liver in the pathogenesis of hepatic complications of inflammatory bowel disease. Lancet (London, England). 2002 Jan 12:359(9301):150-7
[PubMed PMID: 11809275]
[18]
Ludwig J, Barham SS, LaRusso NF, Elveback LR, Wiesner RH, McCall JT. Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis and chronic ulcerative colitis. Hepatology (Baltimore, Md.). 1981 Nov-Dec:1(6):632-40
[PubMed PMID: 7308996]
[19]
Scheuer PJ. Ludwig Symposium on biliary disorders--part II. Pathologic features and evolution of primary biliary cirrhosis and primary sclerosing cholangitis. Mayo Clinic proceedings. 1998 Feb:73(2):179-83
[PubMed PMID: 9473003]
[20]
Burak KW, Angulo P, Lindor KD. Is there a role for liver biopsy in primary sclerosing cholangitis? The American journal of gastroenterology. 2003 May:98(5):1155-8
[PubMed PMID: 12809842]
[21]
European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of cholestatic liver diseases. Journal of hepatology. 2009 Aug:51(2):237-67. doi: 10.1016/j.jhep.2009.04.009. Epub 2009 Jun 6
[PubMed PMID: 19501929]
Level 1 (high-level) evidence
[22]
Björnsson E, Boberg KM, Cullen S, Fleming K, Clausen OP, Fausa O, Schrumpf E, Chapman RW. Patients with small duct primary sclerosing cholangitis have a favourable long term prognosis. Gut. 2002 Nov:51(5):731-5
[PubMed PMID: 12377815]
[23]
Angulo P, Maor-Kendler Y, Lindor KD. Small-duct primary sclerosing cholangitis: a long-term follow-up study. Hepatology (Baltimore, Md.). 2002 Jun:35(6):1494-500
[PubMed PMID: 12029635]
[24]
Gidwaney NG, Pawa S, Das KM. Pathogenesis and clinical spectrum of primary sclerosing cholangitis. World journal of gastroenterology. 2017 Apr 14:23(14):2459-2469. doi: 10.3748/wjg.v23.i14.2459. Epub
[PubMed PMID: 28465630]
[25]
Lee YM, Kaplan MM. Primary sclerosing cholangitis. The New England journal of medicine. 1995 Apr 6:332(14):924-33
[PubMed PMID: 7877651]
[26]
Mendes FD, Jorgensen R, Keach J, Katzmann JA, Smyrk T, Donlinger J, Chari S, Lindor KD. Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis. The American journal of gastroenterology. 2006 Sep:101(9):2070-5
[PubMed PMID: 16879434]
[27]
Hirano K, Kawabe T, Yamamoto N, Nakai Y, Sasahira N, Tsujino T, Toda N, Isayama H, Tada M, Omata M. Serum IgG4 concentrations in pancreatic and biliary diseases. Clinica chimica acta; international journal of clinical chemistry. 2006 May:367(1-2):181-4
[PubMed PMID: 16426597]
[28]
Lindor KD, Kowdley KV, Harrison ME, American College of Gastroenterology. ACG Clinical Guideline: Primary Sclerosing Cholangitis. The American journal of gastroenterology. 2015 May:110(5):646-59; quiz 660. doi: 10.1038/ajg.2015.112. Epub 2015 Apr 14
[PubMed PMID: 25869391]
[29]
Chapman R, Fevery J, Kalloo A, Nagorney DM, Boberg KM, Shneider B, Gores GJ, American Association for the Study of Liver Diseases. Diagnosis and management of primary sclerosing cholangitis. Hepatology (Baltimore, Md.). 2010 Feb:51(2):660-78. doi: 10.1002/hep.23294. Epub
[PubMed PMID: 20101749]
[30]
Dave M, Elmunzer BJ, Dwamena BA, Higgins PD. Primary sclerosing cholangitis: meta-analysis of diagnostic performance of MR cholangiopancreatography. Radiology. 2010 Aug:256(2):387-96. doi: 10.1148/radiol.10091953. Epub
[PubMed PMID: 20656832]
Level 1 (high-level) evidence
[31]
Mendes F, Lindor KD. Primary sclerosing cholangitis: overview and update. Nature reviews. Gastroenterology & hepatology. 2010 Nov:7(11):611-9. doi: 10.1038/nrgastro.2010.155. Epub 2010 Oct 12
[PubMed PMID: 20938459]
Level 3 (low-level) evidence
[32]
Soetikno RM, Lin OS, Heidenreich PA, Young HS, Blackstone MO. Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis. Gastrointestinal endoscopy. 2002 Jul:56(1):48-54
[PubMed PMID: 12085034]
Level 1 (high-level) evidence
[33]
Funiciello AM, Belloli GP. [Problems of anesthesia and resuscitation in the surgical treatment of aortic coarctation in the first year of life]. Acta anaesthesiologica. 1970 Nov-Dec:21(6):777-87
[PubMed PMID: 5538137]
[34]
Kaplan MM. Medical approaches to primary sclerosing cholangitis. Seminars in liver disease. 1991 Feb:11(1):56-63
[PubMed PMID: 2047891]
[35]
Herlong HF, Recker RR, Maddrey WC. Bone disease in primary biliary cirrhosis: histologic features and response to 25-hydroxyvitamin D. Gastroenterology. 1982 Jul:83(1 Pt 1):103-8
[PubMed PMID: 6978827]